Two newly submitted Supreme Court briefs offer opposing views of a dispute that began with surprise medical billing but now concerns how broadly federal courts can remove unlawful agency rules. The November 13 filings address the government’s request for review in Department of Health and Human Services v. Texas Medical Association, No. 26-491. The Court has not listed a grant of review or a ruling on the issue in the docket checked November 15.
The chronology is important. The administration filed its petition on October 14, rather than this weekend. On October 29, the Court extended the respondents’ deadline to December 14. The new entries are submissions from outside organizations, not decisions by the justices and not the medical providers’ response to the petition.
The government asks whether the Administrative Procedure Act permits courts to vacate agency rules for everyone, including people who did not bring the lawsuit, and under what circumstances. Its petition argues that relief should ordinarily be confined to the parties before a court. It also argues that even if broader vacatur is possible, courts should not treat it as the default response to an unlawful rule.
The New Civil Liberties Alliance takes the other side on that procedural question. Although its brief supports neither party in the underlying dispute, it urges the Court to decline review. The organization argues that Congress has accepted and used the established understanding of vacatur, and warns that limiting relief could force similarly situated people to bring many separate lawsuits. Those are the organization’s legal arguments, not findings by the Supreme Court.
Landmark Legal Foundation’s submission urges review of the scope of judicial power. Its brief questions whether the APA authorizes vacatur and points to disagreement among judges and legal scholars. The contrast shows that the dispute concerns competing understandings of judicial restraint: limiting the reach of individual court orders, or enforcing Congress’s limits on administrative agencies.
The underlying appeal comes from the Fifth Circuit’s August 11 decision involving regulations used to calculate payment benchmarks under the No Surprises Act. The broader question in the petition is about the remedy courts may use after finding agency action unlawful. A request to reconsider that remedy is not itself a decision restoring a disputed regulation or changing a patient’s bill.
For readers following federal policy, the immediate checkpoint is the briefing schedule, not a new nationwide legal rule. The respondents have until December 14 under the current extension. Whether the justices will take the case remains unresolved. Any wider effect on regulatory challenges depends on future court action; the opposing briefs illuminate that choice without settling it.
Based on the official docket and filed briefs accessed November 15, 2026. Legal positions are attributed to their proponents; the petition remains pending.
Byline: Scott Bennett, an AI editorial persona. How we use AI ↗




